Browse by Day Archive

Scholar Rock gets first FDA nod for rare muscle-wasting disease

09/11/2026 3:27pm
The U.S. Food and Drug Administration approved ​Scholar Rock's therapy on Friday to treat a rare genetic condition that causes muscle weakness, marking the first regulatory approval for the ‌company.

AstraZeneca's breast cancer pill fails in late-stage trial

09/11/2026 2:33pm
AstraZeneca's breast cancer pill failed to meet the main goal ​of improving progression-free survival in a late-stage trial, the company said on Friday, a week after the treatment received U.S. approval.